Data: NY hospitals fare well in infections Jul 1, 2009
Statewide, coronary artery bypass graft (CABG) chest infection rates also declined from 2007, to a risk-adjusted 2. 1 percent. (Albany Business Review, NY)
Cardica Receives NASDAQ Notification May 23, 2009
Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. (PR Newswire)
CABG: Coronary Artery Bypass Graft May 23, 2009
Coronary artery bypass graft (CABG) surgery is one of the most common major operations ... Coronary artery bypass graft (CABG) surgery is a 3- to 6-hour operation in which the patient's own veins or synthetic grafts are connected to the coronary arteries to allow blood to flow around the blockages (atherosclerotic plaques) ... The coronary artery bypass graft (CABG) surgery is effective at delivering oxygen to the heart muscle and preventing heart attacks. (Suite101.com)
Cardica gets delist warning May 23, 2009
The company focuses on automated anastomosis systems for coronary artery bypass graft surgery. Reader Comments. (San Jose Business Journal, CA)
SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System May 20, 2009
SYNTAX-LE MANS is a substudy of the landmark SYNTAX trial, the first randomized, controlled clinical trial to compare percutaneous coronary intervention (PCI) using the TAXUS Stent to coronary artery bypass graft (CABG) surgery in patients with left main disease and/or significant narrowing of all three coronary arteries (three-vessel disease). The substudy data were presented by A. Pieter Kappetein, M.D., Ph. (PR Newswire)
Waking Up During Surgery: Low-cost Prevention? Apr 7, 2009
23, 2008) Delaying elective coronary artery bypass graft surgery may be a significant risk factor for post-operative death. Research published in the open access journal BMC Health Services Research reveals. (Science Daily)
MEDai Launches Patient-Specific Early Warning System for Hospitals Apr 3, 2009
Known as "never events," these conditions include catheter- and vascular- associated urinary tract infections, decubitus ulcers and mediastinitis after coronary artery bypass graft. Such infections and complications are costly to both hospitals and patients. (Yahoo News -- Press Releases)
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial Feb 19, 2009
In the study, percutaneous coronary intervention (PCI) using the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System was compared to contemporary coronary artery bypass graft (CABG) surgery in patients with the most complex coronary artery disease (CAD). Trial results at 12 months demonstrated no overall statistically significant differences between PCI and CABG in rates of death or myocardial infarction (heart attack), although PCI patients were more likely to require a repeat... (PR Newswire)
Allon Reports 2007 Audited Operating Results and Updates 2008 Plans Mar 19, 2008
- Commencement of the randomized stage of the Phase II clinical trial evaluating AL-208 (intravenous) as a treatment for the mild cognitive impairment (MCI) that commonly results from coronary artery bypass graft (CABG) surgery. The Company expects results of this trial to support additional clinical development in neurodegenerative indications where intravenous or systemic delivery is preferable. (CCNMatthews Press Releases)
60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG Feb 16, 2008
Feb. 15 /PRNewswire/ -- Cory Watson Crowder is, P.C. ), has filed lawsuits against Bayer AG on behalf of plaintiffs throughout the United States, who allegedly suffered permanent kidney damage after being given Trasylol(R) -- a Bayer-manufactured drug used to prevent excessive bleeding during coronary artery bypass graft surgery (also called CABG or more commonly bypass). According to CBS News, 60 Minutes will report Sunday night that 22,000 additional lives could have been saved had the FDA... (PR Newswire)
Baxter's multiple-dose vial Heparin linked to severe allergic ... Feb 12, 2008
Heparin is commonly used before certain types of surgery, including coronary artery bypass graft surgery, and in kidney patients before they undergo dialysis. In some situations, heparin treatment is initiated using a high bolus dose given directly into the bloodstream (intravenously) over a short period of time, usually less than one hour. (News-Medical.net)
Coronary Artery Bypass Graft Surgery Promising In 90-Year-Olds Feb 8, 2008
7, 2008) Coronary artery bypass graft (CABG) surgery is becoming increasingly common, and appears to be a viable treatment, among individuals in their 90s, according to a study published in the American Journal of Cardiology ... 23, 2006) Patients at high-risk of developing pulmonary complications such as pneumonia following coronary artery bypass graft surgery can reduce their risk through breathing exercises and respiratory muscle. (Science Daily)
Biopure Announces 2007 Fourth Quarter and Year-End Financial Results Jan 29, 2008
This trial, begun in 2006, is a Phase 2 clinical trial in patients undergoing multi-vessel coronary artery bypass graft (CABG) surgery. The objective of this trial is to assess the safety and feasibility of Hemopure in reducing heart damage, as measured by cardiac enzyme elevation, and enhancing tissue preservation during CABG surgery. (PR Newswire)
Patient wait times costing economy $14.8B Jan 16, 2008
Coronary artery bypass graft surgery. Magnetic resonance imaging (MRI) scans. (CTV.ca)
Liberal MP wants rush on Mulroney-Schreiber ethics hearings Jan 16, 2008
A senior Liberal MP is advising colleaguesthat he wants federal ethics committee hearings on the Mulroney-Schreiber affair to begin before Parliament returns at the end of the month. In a letter to fellow Liberals on Tuesday, Nova Scotia MP Robert Thibault suggested the House of Commons committee hearings restart a week before Parliament is scheduled to resume business on Jan. 28. (CBC News)
BC's transit upgrade plan gets mixed reviews Jan 16, 2008
B.C.'s transit upgrade plan gets mixed reviews. B.C.'s transit upgrade plan gets mixed reviews. (CBC British Columbia)
Required infection reports would hurt hospitals' mission Jan 11, 2008
One award-winning hospital, by strictly adhering to proven evidence-based practices, virtually eliminated surgical-site infections for coronary artery bypass graft surgeries. Another award-winning hospital system, armed with the goal of being "the cleanest and safest hospitals in the world," incorporated an MRSA (methicillin-resistant Staphylococcus aureus) surveillance system that screens high-risk patients upon admission and allows staff to take precautions that ultimately reduce the risk of... (Atlanta Journal-Constitution -- Opinion)
China suspends sales, use of post-surgical drug aprotinin Dec 18, 2007
Aprotinin is used to reduce blood losses and the need for transfusions in patients undergoing a cardiopulmonary bypass in the course of coronary artery bypass graft surgery. Following an overall safety evaluation, the SFDA concluded that the risks of the drug exceeded its benefits and that it should be taken off the market. (Xinhuanet, China)
Cardica Announces Pricing of $34.7 Million Public Offering of Common Stock Nov 9, 2007
About Cardica Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica provides cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. (PR Newswire)
Statins After Bypass Lower Stroke Risk Nov 8, 2007
TUESDAY, Nov. 6 (HealthDay News) -- Treatment with cholesterol-lowering statin drugs after coronary artery bypass graft (CABG) surgery reduces a patient's risk of stroke, U.S. researchers report. The study, from the Cleveland Clinic, included more than 5,200 patients who underwent bypass between early 1993 and late 2005. (MEDLINEplus)
Voltaren Gel receives FDA approval as first topical prescription treatment for osteoarthritis pain Oct 23, 2007
Voltaren Gel is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. Voltaren Gel should not be used in combination with other oral NSAIDs or aspirin because of the potential for increased adverse effects. (EurekAlert! -- Business News)
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R) Sep 13, 2007
Sept. 12 /PRNewswire/ -- Today, the Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol(R) (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery ... Trasylol(R) is the only drug currently approved by the FDA for prophylactic use to reduce perioperative blood loss and the need for blood transfusion... (PR Newswire)
Allon Named "Top 10" Partnering Candidate by Expert Conference Aug 21, 2007
Allon's third Phase II trial is evaluating a second product, AL-208 as a treatment for the mild cognitive impairment associated with coronary artery bypass graft surgery. About Windhover. (CCNMatthews Press Releases)
Allon Therapeutics Releases Second Quarter Operating Results Aug 11, 2007
The Company's third Phase II efficacy trial is evaluating Al-208 as treatment for the mild cognitive impairment associated with coronary artery bypass graft surgery (MCI-CABG) and the Company is progressing towards its goal of completion by the end of 2007. The Company also announced on May 29th the closing of a bought deal financing generating gross proceeds to Allon of $15. (CCNMatthews Press Releases)
Methodist South wins award for maternal care Jun 21, 2007
Other clinical areas considered for the 2007 Premier Award for Quality were hip and/or knee replacement procedures; coronary artery bypass graft; heart failure; pneumonia; and acute myocardial infarction. Serving 1,700 hospitals and 46,500 other health care sites, Premier is a health care alliance working to improve patient outcomes while safely reducing the cost of care. (Memphis Business Journal, TN)
Hospital chief 'shocked' at disparity in payments Jun 18, 2007
The report showed that during 2005, UPMC Presbyterian and UPMC Shadyside received an average of $34,803 for coronary artery bypass graft surgery -- used on patients with significant artery blockage. The average payment for the same procedure at West Penn Hospital in Bloomfield was $25,184, while at Allegheny General Hospital (another West Penn Allegheny Health facility) on the North Side, the cost was even lower: $23,715. (Pittsburgh Post-Gazette, PA)
Blood Pressure Drop During Bypass Might Impair Thinking Jun 16, 2007
Researchers at the Johns Hopkins University School of Medicine in Baltimore studied 15 patients, aged 57 to 81, who were given cognitive tests before and then three to five days after they had coronary artery bypass graft (CABG) surgery. All the patients had a decrease in mean arterial pressure (MAP) during surgery compared with their MAP before surgery. (MEDLINEplus)
Blood Pressure Drop During Bypass Surgery Associated With Increased Risk Of Cognitive Decline Jun 15, 2007
"Many patients who undergo a coronary artery bypass graft (CABG) operation have pre-existing vascular disease, and a subset have pre-existing cognitive dysfunction," the authors write as background information in the article. "Although recent prospective controlled trials have suggested that CABG may not cause long-term cognitive dysfunction, there may be a subset of patients who experience short-term cognitive problems.". (Science Daily)
UPMC gets paid morefor cardiac surgery Jun 14, 2007
Together, in 2005, the East End hospitals received an average of $34,803 for coronary artery bypass graft surgery -- used on patients with significant artery blockage. No hospital in the area received more. (Pittsburgh Post-Gazette, PA)
Cardiome And Astellas Announce Positive Results From ACT 2 Trial Jun 4, 2007
The trial evaluated the efficacy and safety of the intravenous formulation of vernakalant hydrochloride ("vernakalant (iv)") for the treatment of patients who developed atrial fibrillation or atrial flutter between 24 hours and 7 days following coronary artery bypass graft (CABG) or valve replacement surgery. In the atrial fibrillation population, 47% of patients dosed with vernakalant (iv) experienced conversion to normal heart rhythm within 90 minutes, as compared to 14% of placebo patients, a... (Canada Newswire)
Dyax Jumps on Positive Drug News Apr 14, 2007
Dyax is also developing an alternative treatment for people undergoing coronary artery bypass graft (CABG) surgery, which is typically used for people who have blocked arteries. The company had been collaborating with Genzyme Corp. () on the DX-88's development as a treatment for HAE, but the two mutually decided to stop that arrangement in February 2007. (BusinessWeek)
Atrial Fibrillation Risk Reduced After Cardiac Surgery Through Use of Hydrocortisone Apr 12, 2007
The incidence of AF has been reported to range between 20 percent and 40 percent after coronary artery bypass graft (CABG) surgery and is even higher after heart valve surgery and combined valve and bypass surgery, according to background information in the article. AF is associated with increased illness, including increased risk of stroke and need for additional treatment, with prolonged hospital stay and increased costs. (Science Daily)
Critics blast PM's health targets as 'soft' Apr 5, 2007
Coronary artery bypass graft (CABG) surgery. Common waiting-times benchmarks, meaning the typical time recommended by medical specialists. (Globe and Mail -- National)
LOCAL NEWS BRIEFS Mar 7, 2007
Durham Regional was rated in the top one-tenth percentile in the clinical focus area of coronary artery bypass graft. As a result, DRH will receive a bonus payment of $28,142 from CMS, which has awarded incentive payments of $8. (Herald Sun)
Drug Used In Coronary Artery Bypass Graft Surgery May Increase Risk Of Death Feb 9, 2007
and colleagues assessed survival rates at six weeks, six months and annually for five years for 3,876 patients undergoing coronary artery bypass graft (CABG) surgery at 62 medical centers around the world ... (October 23, 2006) -- Patients at high-risk of developing pulmonary complications such as pneumonia following coronary artery bypass graft surgery can reduce their risk through breathing exercises and respiratory muscle ... (August 25, 2005) -- Boston University School of Medicine (BUSM)... (Science Daily)
Cardica Q2 loss narrows to $2.5M Feb 3, 2007
Cardica, which designs and manufactures automated anastomosis systems for coronary artery bypass graft surgery, said it expects to end fiscal 2007 with cash, cash equivalents and short-term investments of between $12 million and $14 million. Related Industry stories. (San Jose Business Journal, CA)
